|
Philippe Chambon is a Managing Director and concentrates on
pharmaceutical and diagnostics investments. He joined Sprout in May
1995 and became a General Partner in January 1997.
There, he invested broadly in healthcare technology
companies. Previously, Philippe served as Manager in the Healthcare
Practice of The Boston Consulting Group from May 1993 to
April 1995. From September 1987 to April 1993, he was an
executive with Sandoz Pharmaceutical, where he led strategic
product development, portfolio management and pre-marketing
activities in his capacity as Executive Director of New
Product Management. Philippe did
graduate research in molecular immunology at The Pasteur
Institute and earned a M.D., Ph.D. from the University of
Paris. Philippe also has an M.B.A. from Columbia University in
New York.
Board Seats:
Artisan Pharma,
Aureon Laboratories,
Auxilium Pharmaceuticals (AUXL),
BioRelix,
ePocrates,
NxStage Medical (NXTM),
VaxInnate Corporation
Contact Information:
philippe@nlvpartners.com
(646) 871-6400
|
 |
